发明名称 TRANSDERMAL DRUG DELIVERY SYSTEM OF STRYCHNINE, BRUCINE, SECURININE AND THEIR SALTS
摘要 Strychnine, brucine (A) and securinine (B) are a group of natural drugs for central excitation. Because their oral dose or injection dose is close to th e half lethal dose, the drugs, with a great toxic side effect, may be lethal i f improperly used. The invention is characterized by using the transdermal dru g delivery system as a substitute for the oral or injection dosage form to directly act on the local nervous system through the skin, avoiding the toxi c side effect caused by drugs directly entering the blood circulating system. The dose through cutaneous absorption is far lower than the oral or injectio n dose, so it has a much higher safety and a longer acting effect. The transdermal drug delivery system is useful for the treatment of central or peripheral neural paralysis and other nervous system related diseases.</SDOA B>
申请公布号 CA2465349(A1) 申请公布日期 2003.06.12
申请号 CA20022465349 申请日期 2002.10.18
申请人 ZHANG, XITIAN 发明人 ZHANG, XITIAN
分类号 A61K9/06;A61K9/08;A61K9/12;A61K9/70;A61K31/439;A61K31/475;A61K47/06;A61K47/16;A61K47/46;A61P1/00;A61P7/06;A61P11/00;A61P15/00;A61P17/00;A61P19/02;A61P21/04;A61P25/00;A61P25/02;A61P25/18;A61P27/02;(IPC1-7):A61K9/70;A61K9/00;A61K31/55;A61K31/553 主分类号 A61K9/06
代理机构 代理人
主权项
地址